Managing cardiovascular risk in high-risk prostate cancer

Men living with prostate cancer have a high rate of cardiovascular events, and many of them have risk factors that would be an indication for primary prevention under current guidance. These risks may be increased by certain androgen deprivation therapies. This article reports the outcome of a consensus meeting at which the authors discussed these issues. They suggest a simple assessment tool for use with prostate cancer patients to rapidly assess cardiovascular risk and allow appropriate risk-management strategies to be implemented.

Read the full article

Add yours ↓
Web design and marketing agency Leamington Spa